Close Menu

NEW YORK – Noninvasive prenatal testing startup Cradle Genomics said today that it has raised $17.1 million in a Series A funding round.

The funding was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Listwin Ventures, and Axon Ventures.

The company, which is headquartered in San Diego and has R&D operations in Detroit, plans to use the proceeds to support clinical development, corporate infrastructure, CLIA lab operations, and the launch of products for NIPT.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.